These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 1438531

  • 1. Aldose reductase inhibitors and diabetic complications.
    Tomlinson DR, Willars GB, Carrington AL.
    Pharmacol Ther; 1992; 54(2):151-94. PubMed ID: 1438531
    [Abstract] [Full Text] [Related]

  • 2. Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.
    Kador PF, Kinoshita JH, Sharpless NE.
    J Med Chem; 1985 Jul; 28(7):841-9. PubMed ID: 3925146
    [No Abstract] [Full Text] [Related]

  • 3. Aldose reductase inhibitors and the complications of diabetes mellitus.
    Tomlinson DR.
    Diabet Med; 1993 Apr; 10(3):214-30. PubMed ID: 8485953
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
    Hotta N, Sakamoto N.
    Nihon Rinsho; 1987 Dec; 45(12):3010-27. PubMed ID: 3128677
    [No Abstract] [Full Text] [Related]

  • 5. Aldose reductase inhibitors.
    Kirchain WR, Rendell MS.
    Pharmacotherapy; 1990 Dec; 10(5):326-36. PubMed ID: 2122421
    [Abstract] [Full Text] [Related]

  • 6. Aldose reductase inhibitors and diabetic complications.
    Raskin P, Rosenstock J.
    Am J Med; 1987 Aug; 83(2):298-306. PubMed ID: 3113248
    [No Abstract] [Full Text] [Related]

  • 7. [Role of polyols in the development of diabetic complications. Value of aldose-reductase inhibitors].
    Brogard JM, Caro-Sampara F, Blicklé JF.
    Rev Med Interne; 1992 Aug; 13(1):69-79. PubMed ID: 1410879
    [Abstract] [Full Text] [Related]

  • 8. Aldose reductase inhibitors and their potential for the treatment of diabetic complications.
    Tomlinson DR, Stevens EJ, Diemel LT.
    Trends Pharmacol Sci; 1994 Aug; 15(8):293-7. PubMed ID: 7940997
    [Abstract] [Full Text] [Related]

  • 9. Aldose reductase inhibitors and late complications of diabetes.
    Benfield P.
    Drugs; 1986 Aug; 32 Suppl 2():43-55. PubMed ID: 3098544
    [Abstract] [Full Text] [Related]

  • 10. NIH conference. Aldose reductase and complications of diabetes.
    Cogan DG, Kinoshita JH, Kador PF, Robison G, Datilis MB, Cobo LM, Kupfer C.
    Ann Intern Med; 1984 Jul; 101(1):82-91. PubMed ID: 6203454
    [Abstract] [Full Text] [Related]

  • 11. Recent studies of aldose reductase enzyme inhibition for diabetic complications.
    Suzen S, Buyukbingol E.
    Curr Med Chem; 2003 Aug; 10(15):1329-52. PubMed ID: 12871133
    [Abstract] [Full Text] [Related]

  • 12. The role of aldose reductase inhibitors in diabetic complications: recent trends.
    Kaul CL, Ramarao P.
    Methods Find Exp Clin Pharmacol; 2001 Oct; 23(8):465-75. PubMed ID: 11838322
    [Abstract] [Full Text] [Related]

  • 13. Aldose reductase: a window to the treatment of diabetic complications?
    Crabbe MJ, Goode D.
    Prog Retin Eye Res; 1998 Jul; 17(3):313-83. PubMed ID: 9695797
    [Abstract] [Full Text] [Related]

  • 14. [Role of the polyol pathway in the occurrence of degenerative complications of diabetes].
    Bosquet F, Grimaldi A.
    Presse Med; 1986 May 10; 15(19):879-83. PubMed ID: 3012508
    [Abstract] [Full Text] [Related]

  • 15. Clinical experience with sorbinil--an aldose reductase inhibitor.
    Pitts NE, Vreeland F, Shaw GL, Peterson MJ, Mehta DJ, Collier J, Gundersen K.
    Metabolism; 1986 Apr 10; 35(4 Suppl 1):96-100. PubMed ID: 3083213
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of chronic complications of diabetes mellitus with aldose reductase inhibitors].
    Cattalini M, Lerario AC.
    Rev Assoc Med Bras (1992); 1996 Apr 10; 42(2):109-14. PubMed ID: 9110460
    [No Abstract] [Full Text] [Related]

  • 17. Aldose reductase, ocular diabetic complications and the development of topical Kinostat(®).
    Kador PF, Wyman M, Oates PJ.
    Prog Retin Eye Res; 2016 Sep 10; 54():1-29. PubMed ID: 27102270
    [Abstract] [Full Text] [Related]

  • 18. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M, Sharma YR, Cotlier E, Hollander JD.
    Invest Ophthalmol Vis Sci; 1983 Oct 10; 24(10):1426-9. PubMed ID: 6413448
    [Abstract] [Full Text] [Related]

  • 19. Aldose reductase inhibitors: recent developments.
    Sarges R, Oates PJ.
    Prog Drug Res; 1993 Oct 10; 40():99-161. PubMed ID: 8356214
    [No Abstract] [Full Text] [Related]

  • 20. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor.
    Greene DA, Lattimer SA.
    Am J Med; 1985 Nov 15; 79(5A):13-7. PubMed ID: 3000175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.